Sanofi
2 years ago ⋅ English ⋅ 6 min read
Newsroom
Media Update: New data at ERS showed Xenpozyme® (olipudase alfa) improved respiratory functions in adults with ASMD

New data at ERS showed Xenpozyme® (olipudase alfa) improved respiratory functions in adults with ASMDParis, September 14, 2023. New data presented in Milan at the European Respiratory S... Read More
Sanofi
2 years ago ⋅ English ⋅ 6 min read
Newsroom
Media Update: New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditions 

New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditions- Data presentations include landmark results from pivotal t... Read More
Sanofi
2 years ago ⋅ English ⋅ 8 min read
Newsroom
Sanofi announces changes to its Executive Committee

Sanofi announces changes to its Executive CommitteeParis, August 31st, 2023. Sanofi announces the following changes to its Executive Committee:- Houman Ashrafian is appointed as Head of... Read More
Sanofi
2 years ago ⋅ English ⋅ 4 min read
Newsroom
Sanofi, Meningitis Research Foundation, and the Confederation of Meningitis Organisations ignite a global awareness initiative against meningitis with launch of The Meningitis Flag

Sanofi, Meningitis Research Foundation, and the Confederation of Meningitis Organisations ignite a global awareness initiative against meningitis with launch of The Meningitis FlagParis... Read More
Sanofi
2 years ago ⋅ English ⋅ 8 min read
Newsroom
U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease

U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease- Recommendation for use in all infants below 8 mont... Read More
Sanofi
2 years ago ⋅ English ⋅ 1 min read
Newsroom
Online availability of Sanofi’s half-year financial report for 2023

Online availability of Sanofi’s half-year financial report for 2023Paris, July 28, 2023. Sanofi announces that its half-year financial report for the period ending June 30, 2023 is now... Read More